Thus, our work shows that STX4 is a critical component in skeletal muscle mitochondrial homeostasis, providing support for therapeutic targeting of STX4 to improve mitochondrial health in metabolic disorders such as prediabetes and T2D. This evidence concerns the gene STX4 and metabolic disease.